EARLY VS LATE
RRT
Early inititaion
 Pros
 Better control of fluid &electrolyte status,
acid-base homeostasis
 Removal of uremic toxins
 Prevention of complications such as
gastric haemorhage & metabolic
encephalopathy
 Cons
 Mechanical complications
 Bio-incompatibility
 Anticoagulant related
 Hypotension, delayed renal recovery
 Drug clearance & overall cost
1. Gibeneyn, Hostee, Burdmannae etal. Timing of initiation and discontinuation of renal replacement therapy in
aki: un-answered key questions. Clin J Am Soc Nephrol 2008;3:876-80
2. Bagshaw sm, uchino s, bellomo r, et al. timing of renal replacement therapy and clinical outcomes in critically
ill patients with severe aki. J Crit Care 2009;24:129-40
3. Vaara st, reikikainen m, wald r, Bagshaw sm, pettila v. timing of rrt based on the presence of conventional
indications. Clin J Am Soc Nephrol 2014;9:1577-85
AKIKI TRIAL
AKIKI Inclusion criteria
 Adults
 ICU with AKI that was compatible with a diagnosis of ATN in the context of ischemic or
toxic injury
 Invasive mechanical ventilation
 Vasopressors
 Or both
 KDIGO stage 3 AKI
Categorization
Early group
 AKI stage 3
 Mechanical ventilation or vasopressors
or both
 No potentially life threatening
complication directly related to renal
failure
Delayed group
 Oliguria more than 72 hrs after
randomization
 BUN >112 mg/dl
 Severe hyperkalemia
 Severe metabolic acidosis
 Pulmonary edema
Interventions- each study site was free
to decide
 Method of RRT (intermittent or continuous)
 Duration of RRT
 Interval between sessions
 Device settings
 Antoagulation
Discontinuation of RRT
 Considered
 Urine output >550/24 hr
 Highly recommended
 Urine output >1000 ml/24 with no diuretics
 Urine output >2000 ml/24 with diuretics
 Mandatory
 Urine output sufficient to decrease in serum creatinine
AKIKI trial
311 for early
group
308 delayed group
619 underwent
randomisation
5528 pts eligible
for inclusion
KDIGO 3 AKI
Delayed RRT
Conventional
indications
>72 hr after
KDIGO 3 AKI
BUN >112 mg/dl
Early RRT RRT < 12 hr
Result
 No difference in 60 day mortality
 More RRT free days in delayed group
ELAIN
JAMA 2016
Objective
 To determine whether early initiation of RRT in patients who are critically ill patients with
AKI reduces 90 day all cause mortality.
Study design
 Single centre RCT
 University Hospital in Germany
 231 critically ill patients with AKI KDIGO 2
 Plasma NGAL level higher than 150 pg/ml
 Duration: Aug 2013- June 2015
Interventions
 Early- within 8 hrs of diagnosis of AKI stage 2
 Late- within 12 hrs of diagnosis of AKI stage 3
Inclusion in ELAIN
 KDIGO stage 2 AKI
 Plasma NGAL >150 pg/ml
 At least one of the following
 Severe sepsis
 Vasopressors
 Refractory fluid overload
 Non renal organ dysfunction (SOFA >2)
 Age 18-90 years
ELAIN trial
KDIGO AKI 2
Early RRT RRT <8hr
Delayed RRT
<12 hr after
AKI 3
Conventional
indications
ELAIN patient flow
RRT in ELAIN
Identical settings were used in both groups
CVVHDF in all patients
Replacement fluid- Pre filter
Effluent flow- 30 ml/kg/hr
Blood flow >110ml/min
Regional anticoagulation- Citrate
ELAIN
Outcome
ELAIN Conclusion
 Potential benefits of earlier initiation are attributable to
 More rapid metabolic or uremic control
 More effective prevention and management of fluid overload
 RRT before the onset of severe AKI may attenuate
 Kidney specific and non kidney organ injury
 Due to acidemia, uremia, fluid overload and systemic inflammation
 Limitations
 Single centre RCT
 95% patients recruited were surgical patients (limited generalizability)
IDEAL-ICU
NEJM.2018
Inclusion criteria
 >18 years of age
 ICU with septic shock
 AKI with failure stage of RIFLE criteria:
 Oliguria (UO <0.3 ml/kg/hr. >24hrs)
 Anuria for >12 hr. or creatinine 3 times the baseline
IDEAL ICU TRIAL
AKI- RIFLE,
failure stage
Early RRT RRT <12 hr
Delayed RRT
>48 hr after,
AKI-Failure
stage
Conventional
indications
STARRT AKI Trial
• NEJM.2020 (2015-19)
• 168 hospitals in 15 countries
• 11,852 patients met provisional eligibility criteria
• 3019 patients were included
Inclusion criteria
 18 Years or older admitted to an ICU
 KDIGO AKI 2 or 3
Thank you

Presentation AKI RRT INITIATION.pptx

  • 1.
  • 2.
    Early inititaion  Pros Better control of fluid &electrolyte status, acid-base homeostasis  Removal of uremic toxins  Prevention of complications such as gastric haemorhage & metabolic encephalopathy  Cons  Mechanical complications  Bio-incompatibility  Anticoagulant related  Hypotension, delayed renal recovery  Drug clearance & overall cost 1. Gibeneyn, Hostee, Burdmannae etal. Timing of initiation and discontinuation of renal replacement therapy in aki: un-answered key questions. Clin J Am Soc Nephrol 2008;3:876-80 2. Bagshaw sm, uchino s, bellomo r, et al. timing of renal replacement therapy and clinical outcomes in critically ill patients with severe aki. J Crit Care 2009;24:129-40 3. Vaara st, reikikainen m, wald r, Bagshaw sm, pettila v. timing of rrt based on the presence of conventional indications. Clin J Am Soc Nephrol 2014;9:1577-85
  • 4.
  • 5.
    AKIKI Inclusion criteria Adults  ICU with AKI that was compatible with a diagnosis of ATN in the context of ischemic or toxic injury  Invasive mechanical ventilation  Vasopressors  Or both  KDIGO stage 3 AKI
  • 6.
    Categorization Early group  AKIstage 3  Mechanical ventilation or vasopressors or both  No potentially life threatening complication directly related to renal failure Delayed group  Oliguria more than 72 hrs after randomization  BUN >112 mg/dl  Severe hyperkalemia  Severe metabolic acidosis  Pulmonary edema
  • 7.
    Interventions- each studysite was free to decide  Method of RRT (intermittent or continuous)  Duration of RRT  Interval between sessions  Device settings  Antoagulation
  • 8.
    Discontinuation of RRT Considered  Urine output >550/24 hr  Highly recommended  Urine output >1000 ml/24 with no diuretics  Urine output >2000 ml/24 with diuretics  Mandatory  Urine output sufficient to decrease in serum creatinine
  • 9.
    AKIKI trial 311 forearly group 308 delayed group 619 underwent randomisation 5528 pts eligible for inclusion
  • 10.
    KDIGO 3 AKI DelayedRRT Conventional indications >72 hr after KDIGO 3 AKI BUN >112 mg/dl Early RRT RRT < 12 hr
  • 11.
    Result  No differencein 60 day mortality  More RRT free days in delayed group
  • 13.
  • 14.
    Objective  To determinewhether early initiation of RRT in patients who are critically ill patients with AKI reduces 90 day all cause mortality.
  • 15.
    Study design  Singlecentre RCT  University Hospital in Germany  231 critically ill patients with AKI KDIGO 2  Plasma NGAL level higher than 150 pg/ml  Duration: Aug 2013- June 2015
  • 16.
    Interventions  Early- within8 hrs of diagnosis of AKI stage 2  Late- within 12 hrs of diagnosis of AKI stage 3
  • 17.
    Inclusion in ELAIN KDIGO stage 2 AKI  Plasma NGAL >150 pg/ml  At least one of the following  Severe sepsis  Vasopressors  Refractory fluid overload  Non renal organ dysfunction (SOFA >2)  Age 18-90 years
  • 18.
    ELAIN trial KDIGO AKI2 Early RRT RRT <8hr Delayed RRT <12 hr after AKI 3 Conventional indications
  • 19.
  • 21.
    RRT in ELAIN Identicalsettings were used in both groups CVVHDF in all patients Replacement fluid- Pre filter Effluent flow- 30 ml/kg/hr Blood flow >110ml/min Regional anticoagulation- Citrate
  • 22.
  • 25.
    ELAIN Conclusion  Potentialbenefits of earlier initiation are attributable to  More rapid metabolic or uremic control  More effective prevention and management of fluid overload  RRT before the onset of severe AKI may attenuate  Kidney specific and non kidney organ injury  Due to acidemia, uremia, fluid overload and systemic inflammation  Limitations  Single centre RCT  95% patients recruited were surgical patients (limited generalizability)
  • 27.
  • 28.
    Inclusion criteria  >18years of age  ICU with septic shock  AKI with failure stage of RIFLE criteria:  Oliguria (UO <0.3 ml/kg/hr. >24hrs)  Anuria for >12 hr. or creatinine 3 times the baseline
  • 29.
    IDEAL ICU TRIAL AKI-RIFLE, failure stage Early RRT RRT <12 hr Delayed RRT >48 hr after, AKI-Failure stage Conventional indications
  • 34.
    STARRT AKI Trial •NEJM.2020 (2015-19) • 168 hospitals in 15 countries • 11,852 patients met provisional eligibility criteria • 3019 patients were included
  • 35.
    Inclusion criteria  18Years or older admitted to an ICU  KDIGO AKI 2 or 3
  • 40.